Clinical Trial Update: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, tolerability, efficacy, and pharmacokinetics of HEC96719 in non-cirrhotic non-alcoholic steatohepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• HEC96719

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Non-Alcoholic Steatohepatitis | Phase 2 | Status: COMPLETED